These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


672 related items for PubMed ID: 14961146

  • 1. Coagulopathy of sepsis.
    Dempfle CE.
    Thromb Haemost; 2004 Feb; 91(2):213-24. PubMed ID: 14961146
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Coagulation tests in septic surgical patients].
    Oberhofer D, Kucisec-Tepes N, Skok J, Vucić N, Cala K.
    Acta Med Croatica; 2004 Feb; 58(5):389-94. PubMed ID: 15756805
    [Abstract] [Full Text] [Related]

  • 5. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
    Ettingshausen CE, Veldmann A, Beeg T, Schneider W, Jäger G, Kreuz W.
    Semin Thromb Hemost; 1999 Feb; 25(6):537-41. PubMed ID: 10632475
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation.
    Cauchie P, Cauchie Ch, Boudjeltia KZ, Carlier E, Deschepper N, Govaerts D, Migaud-Fressart M, Woodhams B, Brohée D.
    Am J Hematol; 2006 Jun; 81(6):414-9. PubMed ID: 16680742
    [Abstract] [Full Text] [Related]

  • 9. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
    Mosad E, Elsayh KI, Eltayeb AA.
    Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
    de Jonge E, van der Poll T, Kesecioglu J, Levi M.
    Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
    [Abstract] [Full Text] [Related]

  • 17. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.